Vycor Medical has secured Hong Kong Patent No. 10106385.8 for its ViewSite brain access system (VBAS) for the Hong Kong market. The company has a distribution agreement with Devon Medical, which covers Hong Kong and China.
VBAS is a suite of clear cylindrical disposable devices that provide neurosurgeons a stable, minimally-invasive working channel to access targeted sites within the brain, such as tumours. The system is designed to optimise neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the medical community. The system has been approved in over 100 hospitals in the US. VBAS is ISO 13485:2003-compliant, has FDA 510(k) clearance for brain and spine surgeries and regulatory approvals for brain surgeries in Australia, Canada, China, Europe, Japan, South Korea and Russia. Vycor has distribution agreements in place for VBAS in a number of markets.